

Publisher: John Wiley & Sons Inc
E-ISSN: 1365-2516|24|1|17-19
ISSN: 1351-8216
Source: HAEMOPHILIA, Vol.24, Iss.1, 2018-01, pp. : 17-19
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content


Biosimilars and Regulatory Authorities
Nephron Clin Pract, Vol. 117, Iss. 1, 2010-08 ,pp. :


The State of the Art in the Development of Biosimilars
CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 91, Iss. 3, 2012-03 ,pp. :


Worldwide perspective of biosimilars for psoriasis
BRITISH JOURNAL OF DERMATOLOGY, Vol. 177, Iss. 6, 2017-12 ,pp. :


Biosimilars und Patientenversorgung
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, Vol. 16, Iss. 2, 2018-02 ,pp. :